查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018958

醫用黏合劑市場：按產品類型、原料、應用和最終用戶分類－2026-2032年全球市場預測

Medical Adhesives Market by Product Type, Raw Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫用黏合劑市場價值將達到 120.5 億美元，到 2026 年將成長至 130.3 億美元，到 2032 年將達到 208.7 億美元，複合年成長率為 8.15%。

主要市場統計數據
基準年 2025 120.5億美元
預計年份：2026年 130.3億美元
預測年份 2032 208.7億美元
複合年成長率 (%) 8.15%

對醫用黏合劑市場進行策略性介紹，重點在於臨床需求、材料進步、製造技術發展和監管趨勢。

本執行摘要首先清楚概述了現代醫用黏合劑市場，並說明了影響產品開發、臨床應用和供應鏈趨勢的根本因素。文章重點闡述了材料科學的進步、不斷發展的臨床方案以及日益嚴格的過程如何使黏合劑從普通商品組件躍升為患者照護過程中不可或缺的要素。

對醫用黏合劑的關鍵變革進行深入分析，重點關注數位化製造、新型化學技術、永續發展趨勢和臨床整合。

在這個領域，一系列變革正在發生，這些變革超越了簡單的產品改進，重新定義了黏合劑的設計、規格製定和採購流程。在材料方面，配方研發人員正轉向研發兼顧黏合性能、生物相容性和易去除性的化學成分，並將臨床醫生的回饋和患者的舒適度放在首位。同時，生產流程也日益數位化，從而提高了生產效率，加強了流程控制，並實現了更穩定的品質結果——所有這些特性對於無菌一次性應用至關重要。

對 2025 年美國關稅對醫用黏合劑。

美國於2025年實施的關稅政策對整個醫用黏合劑鏈上的相關人員的採購和成本結構產生了重大影響。供應商和買家被迫重新評估其供應商多元化、物流規劃和庫存策略，以降低到貨成本上升和運輸成本波動帶來的風險。這些調整促使各方更加重視盡可能進行在地化生產，並採用合約機制來分擔買賣雙方之間的關稅風險。

透過細分市場洞察，揭示產品類型、原料、應用和最終用戶趨勢如何推動創新、臨床應用和採購選擇。

市場區隔提供了一個實用的觀點，幫助我們理解產品、材料、應用和最終用戶等維度上的性能、監管負擔和商業性機會之間的相互影響。基於產品類型，我們將市場分為黏合劑、液體黏合劑、壓敏黏著劑和反應型黏合劑。這種分類突顯了配方優先順序的差異，例如是否需要耐熱處理性能，或優先考慮低溫性能或長期黏合穩定性。基於原料，我們根據化學成分（例如丙烯酸酯、橡膠和矽酮）分析市場。這種分類突顯了黏性、生物相容性和基材通用性之間的權衡。

透過對美洲、歐洲、中東和非洲以及亞太地區的比較，區域洞察揭示了需求推動要素、監管環境和供應韌性。

區域趨勢對全球醫用黏合劑市場的產品規格、監管策略和供應商參與度有顯著影響。在美洲，買家優先考慮產品上市速度、可靠的上市後監控數據和供應穩定性，促使供應商優先考慮快速的物流反應和完善的品管系統。在歐洲、中東和非洲，監管協調統一的壓力正在影響對應用文件的期望，而成本敏感性和基於價值的採購模式則影響著與供應商就總體擁有成本進行的討論。在亞太地區，快速擴大生產規模的能力和不斷完善的臨床基礎設施為本地創新以及能夠證明其合規性和具有競爭力的生產成本的供應商創造了機會。

公司層面的關鍵亮點包括研發重點、併購活動、製造地最佳化以及與臨床合作夥伴的合作模式。

該產業的企業發展趨勢反映了兩大關鍵優先事項：技術差異化和營運穩健性。主要企業正集中研發能夠提高生物相容性、增強對敏感皮膚的可預測黏附性以及與監測電子設備相容性的化學技術。同時，企業正透過有針對性的夥伴關係、產能擴張和選擇性併購等策略措施，確保原料供應管道暢通、縮短新配方上市時間並提升合規性。

為產業領導者提供加速創新、增強供應鏈韌性、最佳化採購和提高合規性的實用建議。

產業領導者應優先考慮一系列切實可行的舉措，將策略意圖轉化為實際營運成果。首先，應加速推進針對關鍵臨床挑戰的創新項目，而非進行大範圍、無差別的配方變更。其次，應透過多元化認證供應商、探索近岸生產能力以及在商業合約中納入關稅和物流應急計畫，以增強價值鏈的韌性。這些措施將在不犧牲產品品質的前提下，降低風險敞口，提升談判優勢。

一種高度透明的調查方法，概述了支持調查結果的數據收集、一級和二級調查、檢驗過程和分析方法。

本執行摘要所依據的研究透過結合與關鍵相關人員的初步定性研究和嚴謹的二手資訊整合，確保了研究的深度和檢驗。初步研究包括對臨床使用者、採購經理、研發科學家和生產合作夥伴進行結構化訪談，以獲取關於績效預期、採購槓桿和推廣障礙的第一手觀點。訪談結果透過有針對性的後續跟進進行交叉檢驗，以確認關鍵假設並識別不同終端使用者群體之間的差異。

對創新、監管、採購和臨床部署等方面的策略見解進行簡潔整合，並為相關人員。

總之，本報告整合了醫療黏合劑產業企業最重要的洞見，並以清晰簡潔的方式總結了策略重點。材料和製造技術的進步為滿足尚未滿足的臨床需求創造了機遇，但要抓住這些機遇，還需要同時投資於監管準備、臨床檢驗和供應鏈穩健性。能夠使產品性能與臨床醫生工作流程和患者舒適度相匹配的企業更有可能實現永續的市場推廣。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 醫用黏合劑市場：依產品類型分類

  • 黏合劑
  • 液體黏合劑
  • 壓敏黏著劑
  • 反應型黏合劑

第9章 醫用黏合劑市場：依原料分類

  • 丙烯酸纖維
  • 橡膠基
  • 矽基

第10章 醫用黏合劑市場：依應用領域分類

  • 診斷
  • 固定電極
  • 整形外科固定
  • 傷口縫合

第11章 醫用黏合劑市場：依最終用戶分類

  • 診所
  • 居家照護
  • 醫院

第12章 醫用黏合劑市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 醫用黏合劑市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 醫用黏合劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國醫用黏合劑市場

第16章：中國醫用黏合劑市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • 3M Company
  • Advanced Medical Solutions Group PLC
  • Avery Dennison Corporation
  • B. Braun Melsungen AG
  • Berry Global Group, Inc.
  • Eloquest Healthcare, Inc. by Ferndale Pharma Group, Inc.
  • GluStitch Inc.
  • HB Fuller Company
  • Henkel AG & Co. KGaA
  • Johnson & Johnson Services, Inc.
  • Lohmann GmbH & Co. KG
  • Medtronic PLC
  • Nitto Denko Corporation
  • Panacol-Elosol GmbH
  • Permabond LLC
  • Scapa Group plc
  • Sika AG
  • TELA Bio, Inc.
  • The Dow Chemical Company
  • Urocare Products, Inc.
Product Code: MRR-EC2E133E327A

The Medical Adhesives Market was valued at USD 12.05 billion in 2025 and is projected to grow to USD 13.03 billion in 2026, with a CAGR of 8.15%, reaching USD 20.87 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 12.05 billion
Estimated Year [2026] USD 13.03 billion
Forecast Year [2032] USD 20.87 billion
CAGR (%) 8.15%

A strategic introduction to the medical adhesives landscape highlighting clinical demands, material evolution, manufacturing advances, and regulatory dynamics

This executive summary opens with a clear orientation to the modern medical adhesives landscape, describing the underlying forces that are shaping product development, clinical adoption, and supply chain behavior. The narrative emphasizes how advances in materials science, coupled with shifting clinical protocols and heightened regulatory scrutiny, have combined to elevate adhesives from commodity components to critical enablers of patient care pathways.

The introduction situates recent innovations-such as more biocompatible chemistries and manufacturing process improvements-against operational realities including sterilization compatibility and packaging integrity. It also contextualizes the role of adhesives within broader clinical device ecosystems where adhesion performance impacts wound healing, electrode stability, and immobilization in orthopedic procedures. By framing these dynamics up front, the introduction sets expectations for subsequent sections that explore technological inflection points, regional nuances, tariff implications, and segment-specific behaviors. The tone is strategic and pragmatic, intended for executives, product leads, and procurement managers who require both a panoramic view and direct linkages to decision-focused implications.

An incisive exploration of major shifts in medical adhesives, focusing on digital fabrication, novel chemistries, sustainability trends, and clinical integration

The sector is experiencing a cluster of transformative shifts that extend beyond incremental product improvements to redefine how adhesives are designed, specified, and procured. On the materials front, formulators are migrating toward chemistries that balance adhesion performance with cytocompatibility and ease of removal, driven by clinician feedback and patient comfort priorities. At the same time, manufacturing is becoming increasingly digitized, enabling higher throughput, tighter process control, and more consistent quality outcomes-attributes that matter for sterile, single-use applications.

Sustainability considerations are also influencing raw material selection and packaging design, with procurement teams requiring clearer life-cycle narratives from suppliers. Clinically, there is heightened demand for adhesives that integrate with monitoring systems, maintain signal integrity for electrodes, and support minimally invasive orthopedic stabilization. Regulatory expectations continue to tighten, prompting manufacturers to invest in more robust documentation and testing pathways. Collectively, these shifts are prompting cross-functional alignment among R&D, quality, and commercial teams, and are reshaping the supplier landscape toward partners who can demonstrate both technical depth and operational reliability.

A focused assessment of how United States tariffs in 2025 influenced medical adhesives supply chains, procurement behavior, sourcing, and cost dynamics

The imposition of United States tariffs in 2025 has had a material effect on how stakeholders approach sourcing and cost structures across the medical adhesives value chain. Suppliers and purchasers have had to reassess supplier diversification, logistics planning, and inventory policies in order to mitigate exposure to increased landed costs and transit volatility. These adjustments have led to renewed emphasis on localized manufacturing footprints where feasible, and on contractual mechanisms that share tariff risk between buyers and sellers.

Procurement teams have also accelerated conversations around formulation standardization to reduce part complexity and to increase leverage with qualified suppliers. Clinical teams, in turn, are sensitive to any potential disruptions that might affect product availability, and are collaborating more closely with supply chain leaders to define acceptable cross-qualified alternatives. From a commercialization standpoint, organizations are prioritizing transparency in cost build-ups and are exploring hedging and longer-term supplier commitments to preserve continuity of care. While tariffs have introduced near-term complexity, they have also catalyzed more rigorous supplier qualification and contingency planning across the ecosystem.

Segmentation insights illuminating how product type, raw material, application, and end-user dynamics drive innovation, clinical uptake, and procurement choices

Segmentation provides a practical lens for understanding where performance, regulatory burden, and commercial opportunity intersect across product, material, application, and end-user dimensions. Based on Product Type, market is studied across Hot Melt Adhesive, Liquid Adhesive, Pressure Sensitive Adhesive, and Reactive Adhesive, and this classification highlights divergent formulation priorities where some types demand thermal processing robustness while others prioritize low-temperature performance or long-term bonding stability. Based on Raw Material, market is studied across Acrylic Based, Rubber Based, and Silicone Based chemistries, a distinction that underscores trade-offs between tack, biocompatibility, and substrate versatility.

Based on Application, market is studied across Diagnostics, Electrode Fixation, Orthopedic Fixation, and Wound Closure, which illuminates how adhesion requirements are driven by use-case specifics such as signal fidelity for diagnostics or secure fixation under biomechanical load for orthopedic uses. Based on End User, market is studied across Clinics, Home Care, and Hospitals, revealing variation in procurement cycles, sterilization expectations, and user training demands. Together, these segmentation perspectives illuminate where development investments should concentrate, how regulatory strategies must be tailored, and which commercial channels warrant prioritized engagement to accelerate acceptance and scale.

Regional insights comparing Americas, Europe Middle East & Africa, and Asia-Pacific to reveal demand drivers, regulatory landscapes, and supply resilience

Regional dynamics materially influence product specification, regulatory strategy, and supplier engagement across the global medical adhesives landscape. In the Americas, buyers emphasize speed to market, strong post-market surveillance data, and supply continuity, prompting suppliers to prioritize responsive logistics and robust quality systems. In Europe, Middle East & Africa, regulatory alignment and harmonization pressures are shaping dossier expectations, while cost-sensitivity and value-based procurement models influence supplier discussions on total cost of ownership. In the Asia-Pacific region, rapid manufacturing scale-up capabilities and expanding clinical infrastructure are creating opportunities for localized innovation and for suppliers that can demonstrate both compliance and competitive production economics.

These regional contrasts have operational implications: design-for-manufacturability choices must consider regulatory submission pathways and sterilization standards that vary by jurisdiction, and commercialization strategies need to reflect channel structures that differ significantly between hospital systems, clinic networks, and home care distribution. Moreover, geopolitical developments and logistics constraints can alter supplier selection criteria, making it essential for companies to embed regional scenario planning into product roadmap and supply chain strategies to preserve resilience and to maximize access across diverse healthcare markets.

Key company-level insights highlighting R&D focus, M&A activity, manufacturing footprint optimization, and collaborative models with clinical partners

Company behavior in this sector demonstrates a dual focus on technological differentiation and operational robustness. Leading manufacturers are concentrating R&D efforts on chemistries that deliver enhanced biocompatibility, predictable adhesion for sensitive skin, and compatibility with monitoring electronics. At the same time, strategic moves such as targeted partnerships, capacity expansions, and selective M&A are being used to secure raw material pipelines, accelerate time-to-market for new formulations, and broaden regulatory footprints.

There is also a clear trend toward collaborative models that bring suppliers, clinicians, and contract manufacturers into earlier-stage co-development discussions. This shift reduces iteration cycles and increases the likelihood of clinical acceptance by aligning performance attributes with real-world workflows. For companies evaluating their competitive posture, the emphasis is on demonstrating validated performance under clinically relevant conditions, investing in regulatory readiness, and ensuring manufacturing scalability. Those that can couple compelling technical differentiation with supply chain transparency and certification are better positioned to win long-term institutional contracts and to support home care and clinic-level adoption.

Practical recommendations for industry leaders to accelerate innovation, reinforce supply chain resilience, optimize procurement, and improve regulatory alignment

Industry leaders should prioritize a set of pragmatic actions that translate strategic intent into operational outcomes. First, accelerate targeted innovation projects that solve high-value clinical pain points rather than pursuing broad, undifferentiated formulation changes. Second, strengthen supply chain resilience by diversifying qualified suppliers, assessing near-shore capacity options, and embedding tariff and logistics contingencies into commercial agreements. These steps reduce exposure and increase negotiating leverage without sacrificing quality.

Third, align regulatory strategies with clinical evidence generation by designing validation programs that reflect end-user conditions and by investing in post-market surveillance to substantiate safety and performance claims. Fourth, optimize procurement engagement by offering multi-tiered product portfolios that accommodate both institutional tenders and the growing home care channel. Finally, cultivate closer collaboration between R&D, quality, and commercialization teams to shorten time-to-adoption and to ensure that launch packs, training materials, and technical support address real-world use. Taken together, these recommendations help organizations balance short-term continuity with long-term differentiation.

Transparent methodology outlining data collection, primary and secondary research, validation processes, and analytical techniques that underpin findings

The research underpinning this executive summary combines primary qualitative engagement with key stakeholders and rigorous secondary-source synthesis to ensure both depth and triangulation. Primary work included structured interviews with clinical users, procurement leaders, R&D scientists, and manufacturing partners to capture first-hand perspectives on performance expectations, procurement levers, and adoption barriers. Interview findings were cross-validated through targeted follow-ups to confirm critical assumptions and to map divergence across end-user segments.

Secondary research comprised an analysis of regulatory guidance, technical standards, patent activity, and published clinical literature to contextualize formulation trends and to identify validated performance measures. Validation frameworks were applied to reconcile divergent inputs, test hypotheses about supply chain behavior, and confirm the applicability of recommended actions across regions and end-user settings. Analytical techniques included qualitative thematic coding and comparative scenario analysis to translate signals from interviews and documents into actionable implications. The methodology emphasizes transparency, reproducibility, and practical orientation so that findings can be applied directly to business planning and product development choices.

Concise synthesis of strategic implications across innovation, regulation, sourcing, and clinical adoption, setting actionable next steps for stakeholders

The conclusion synthesizes the most consequential implications for organizations operating in the medical adhesives space and offers a crisp summary of strategic priorities. Technological progress in materials and manufacturing is creating opportunities to address unmet clinical needs, but realizing that potential requires concurrent investments in regulatory preparation, clinical validation, and supply chain robustness. Companies that align product performance with clinician workflows and patient comfort are more likely to achieve durable adoption.

Regional nuances and tariff developments underscore the need for flexible sourcing strategies and for scenario-based planning. Segmentation-aware product roadmaps, where formulations are tailored to specific applications and end-user requirements, will outperform one-size-fits-all approaches. Finally, organizational alignment across R&D, quality, and commercial functions is a critical enabler of speed and consistency during product launches. Embracing these priorities positions companies to convert technical capability into operational advantage and to support safer, more reliable clinical outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Adhesives Market, by Product Type

  • 8.1. Hot Melt Adhesive
  • 8.2. Liquid Adhesive
  • 8.3. Pressure Sensitive Adhesive
  • 8.4. Reactive Adhesive

9. Medical Adhesives Market, by Raw Material

  • 9.1. Acrylic Based
  • 9.2. Rubber Based
  • 9.3. Silicone Based

10. Medical Adhesives Market, by Application

  • 10.1. Diagnostics
  • 10.2. Electrode Fixation
  • 10.3. Orthopedic Fixation
  • 10.4. Wound Closure

11. Medical Adhesives Market, by End User

  • 11.1. Clinics
  • 11.2. Home Care
  • 11.3. Hospitals

12. Medical Adhesives Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Medical Adhesives Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Medical Adhesives Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Medical Adhesives Market

16. China Medical Adhesives Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. 3M Company
  • 17.6. Advanced Medical Solutions Group PLC
  • 17.7. Avery Dennison Corporation
  • 17.8. B. Braun Melsungen AG
  • 17.9. Berry Global Group, Inc.
  • 17.10. Eloquest Healthcare, Inc. by Ferndale Pharma Group, Inc.
  • 17.11. GluStitch Inc.
  • 17.12. H.B. Fuller Company
  • 17.13. Henkel AG & Co. KGaA
  • 17.14. Johnson & Johnson Services, Inc.
  • 17.15. Lohmann GmbH & Co. KG
  • 17.16. Medtronic PLC
  • 17.17. Nitto Denko Corporation
  • 17.18. Panacol-Elosol GmbH
  • 17.19. Permabond LLC
  • 17.20. Scapa Group plc
  • 17.21. Sika AG
  • 17.22. TELA Bio, Inc.
  • 17.23. The Dow Chemical Company
  • 17.24. Urocare Products, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL ADHESIVES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL ADHESIVES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOT MELT ADHESIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOT MELT ADHESIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOT MELT ADHESIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY LIQUID ADHESIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY LIQUID ADHESIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY LIQUID ADHESIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY PRESSURE SENSITIVE ADHESIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY PRESSURE SENSITIVE ADHESIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY PRESSURE SENSITIVE ADHESIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY REACTIVE ADHESIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY REACTIVE ADHESIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY REACTIVE ADHESIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ACRYLIC BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ACRYLIC BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ACRYLIC BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY RUBBER BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY RUBBER BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY RUBBER BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY SILICONE BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY SILICONE BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY SILICONE BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ELECTRODE FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ELECTRODE FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ELECTRODE FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ORTHOPEDIC FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ORTHOPEDIC FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY ORTHOPEDIC FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY WOUND CLOSURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY WOUND CLOSURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY WOUND CLOSURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS MEDICAL ADHESIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA MEDICAL ADHESIVES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. MIDDLE EAST MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. AFRICA MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 82. AFRICA MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. ASEAN MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 93. ASEAN MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. ASEAN MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. GCC MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GCC MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. GCC MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 98. GCC MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. GCC MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPEAN UNION MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPEAN UNION MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPEAN UNION MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPEAN UNION MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPEAN UNION MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. BRICS MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. BRICS MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. BRICS MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 108. BRICS MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. BRICS MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. G7 MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. G7 MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. G7 MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 113. G7 MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. G7 MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. NATO MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. NATO MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. NATO MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. NATO MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. NATO MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL ADHESIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. UNITED STATES MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. UNITED STATES MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. UNITED STATES MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. UNITED STATES MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. UNITED STATES MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. CHINA MEDICAL ADHESIVES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. CHINA MEDICAL ADHESIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. CHINA MEDICAL ADHESIVES MARKET SIZE, BY RAW MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. CHINA MEDICAL ADHESIVES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. CHINA MEDICAL ADHESIVES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)